1. Pink Sheet
  2. >>Pathways & Standards
  3. >>Approval Standards

States Ease Access To Oral Contraceptives Despite Rx Requirement

Changes range from allowing pharmacists to prescribe the drugs to requiring insurers to insurers to cover purchases of the products.

While women's health care advocates urge FDA to move from requiring prescriptions for all daily-use oral contraceptives and allowing OTC sales of some, several states already are lowering barriers to accessing the products.

The changes range from allowing pharmacists to prescribe the drugs to requiring insurers to insurers to cover purchases of the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approval Standards

More from Pathways & Standards

Generic Drugs And AI: Maximum Daily Dose Tool Could Help US FDA Be ‘At The Forefront’

 
• By Michael McCaughan

The FDA is testing a new artificial intelligence tool to help generic drug developers automate maximum daily dose calculations.

Faster HTA Reviews & Pricing Reform Could Help Fix Canada’s Drug Access Woes

 
• By Eliza Slawther

Canadian politicians must “move quickly” to introduce policies that will speed up access to medicines, such as by broadening criteria for the temporary reimbursement of medicines, the Canadian Chamber of Commerce says.

New EU Filings

 
• By Neena Brizmohun

Arimoclomol, Zevra Therapeutics's treatment for Niemann-Pick disease Type C, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.